Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Targeting Transcriptional Addictions in Small Cell Lung Cancer with a Covalent CDK7 Inhibitor (ChIP-seq)


ABSTRACT: Small cell lung cancer (SCLC) is an aggressive disease with high mortality. The identification of effective pharmacological strategies to target SCLC biology represents an urgent need. Using a high-throughput cellular screen of a diverse chemical library we observe that SCLC is sensitive to transcription-targeting drugs, and in particular to THZ1, a newly identified covalent inhibitor of cyclin-dependent kinase 7 (CDK7). We find that expression of super-enhancer associated transcription factor genes including MYC family proto-oncogenes and neuroendocrine lineage-specific factors are highly vulnerability to THZ1 treatment. We propose that downregulation of these transcription factors contributes, in part, to SCLC sensitivity to transcriptional inhibitors and that THZ1 represents a novel treatment paradigm for targeted SCLC therapy. ChIP-Seq for H3K27ac in small cell lung cancer lines

ORGANISM(S): Homo sapiens

SUBMITTER: Richard Young 

PROVIDER: E-GEOD-62412 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2014-10-23 | E-GEOD-62609 | biostudies-arrayexpress
2014-10-23 | E-GEOD-62614 | biostudies-arrayexpress
2012-12-01 | E-GEOD-40564 | biostudies-arrayexpress
2012-06-02 | E-GEOD-38411 | biostudies-arrayexpress
2014-10-23 | GSE62609 | GEO
2014-10-23 | GSE62412 | GEO
2020-05-13 | E-MTAB-8380 | biostudies-arrayexpress
2020-06-17 | PXD017704 | Pride
2013-02-17 | E-GEOD-43583 | biostudies-arrayexpress
2014-01-01 | E-GEOD-52649 | biostudies-arrayexpress